We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+10.66%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$1.22B
AUM Growth
-$94.6M
Cap. Flow
-$235M
Cap. Flow %
-19.18%
Top 10 Hldgs %
48.81%
Holding
242
New
17
Increased
38
Reduced
145
Closed
16

Sector Composition

Rank Sector Weight
1 Financials 3.73%
2 Technology 3.01%
3 Communication Services 2.08%
4 Healthcare 1.51%
5 Consumer Discretionary 0.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
76
Cisco
CSCO
$436B
$2.15M 0.18%
39,780
+15,056
+61% +$732K
IFGL icon
77
iShares International Developed Real Estate ETF
IFGL
$81.7M
$2.12M 0.17%
69,695
-27,471
-28% -$803K
BRK.A icon
78
Berkshire Hathaway Class A
BRK.A
$1.06T
$2.11M 0.17%
9
+1
+13% +$303K
RTN
79
DELISTED
Raytheon Company
RTN
$2.04M 0.17%
11,173
-770
-6% -$134K
AMZN icon
80
Amazon
AMZN
$2.69T
$2.02M 0.17%
22,700
-9,740
-30% -$811K
SCHW
81
Charles Schwab
SCHW
$178B
$1.98M 0.16%
46,309
-2,683
-5% -$121K
DHR icon
82
Danaher
DHR
$142B
$1.82M 0.15%
15,560
-1,889
-11% -$194K
SCHE icon
83
Schwab Emerging Markets Equity ETF
SCHE
$12.4B
$1.71M 0.14%
65,966
-7,401
-10% -$188K
MDY icon
84
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$1.67M 0.14%
4,823
-27
-0.6% -$9.08K
WFC icon
85
Wells Fargo
WFC
$261B
$1.66M 0.14%
34,392
-10,191
-23% -$501K
AMJ
86
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$1.66M 0.14%
65,051
-30,914
-32% -$772K
VZ icon
87
Verizon
VZ
$182B
$1.63M 0.13%
27,558
-4,254
-13% -$241K
CMCSA icon
88
Comcast
CMCSA
$84.9B
$1.63M 0.13%
40,661
-5,879
-13% -$221K
IGSB icon
89
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
$1.6M 0.13%
30,261
NEE icon
90
NextEra Energy
NEE
$184B
$1.56M 0.13%
32,084
-2,596
-7% -$119K
BSV icon
91
Vanguard Short-Term Bond ETF
BSV
$44.7B
$1.52M 0.12%
19,095
-7,928
-29% -$626K
XOM icon
92
ExxonMobil
XOM
$615B
$1.52M 0.12%
18,804
-2,785
-13% -$212K
ALGN icon
93
Align Technology
ALGN
$12.5B
$1.29M 0.11%
4,548
+7
+0.2% +$1.67K
IWF icon
94
iShares Russell 1000 Growth ETF
IWF
$123B
$1.27M 0.1%
33,580
QEMM icon
95
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$53.5M
$1.27M 0.1%
21,433
-311
-1% -$18.1K
QCOM icon
96
Qualcomm
QCOM
$180B
$1.27M 0.1%
22,092
-3,111
-12% -$168K
TOTL icon
97
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.14B
$1.24M 0.1%
25,910
-5,727
-18% -$273K
VTV icon
98
Vanguard Value ETF
VTV
$185B
$1.22M 0.1%
11,318
+2,386
+27% +$251K
MRK icon
99
Merck
MRK
$307B
$1.22M 0.1%
15,378
-5,110
-25% -$382K
IWN icon
100
iShares Russell 2000 Value ETF
IWN
$14.3B
$1.17M 0.1%
9,791
-6,411
-40% -$766K

Similar funds

Aspiriant LLC's Q1 2019 Portfolio in Review

As of Q1 2019, Aspiriant LLC held 242 positions worth $1.22B, down 7.2% from $1.32B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Aspiriant LLC withdrew a net $235M in Q1 2019, closing 16 positions and reducing 145 holdings. Its most notable exit was iShares iBonds Dec 2024 Term Corporate ETF, an estimated $3.03M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.7% of assets, down from 4.1% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Aspiriant LLC opened a new position in Vanguard Total World Stock ETF worth $4.05M.

  • Aspiriant LLC's largest Q1 2019 buy was Vanguard Total World Stock ETF: 55,319 shares worth $4.05M.
  • Aspiriant LLC added most to Vanguard Global ex-US Real Estate ETF in Q1 2019, an estimated $4.58M increase.
  • Aspiriant LLC's biggest Q1 2019 reduction was NYLI Hedge Multi-Strategy Tracker ETF, cutting an estimated $50.6M.
  • Aspiriant LLC fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q1 2019, selling an estimated $3.03M.
  • Aspiriant LLC's ten largest holdings make up 49% of its $1.22B portfolio in Q1 2019.
  • Aspiriant LLC opened 17 new positions and closed 16 in Q1 2019.
  • Aspiriant LLC's portfolio value fell 7.2% quarter-over-quarter to $1.22B.

Based on Aspiriant LLC's 13F filing for Q1 2019, filed 3 May 2019.